The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1 million in 2025 and an impressive US$3,261.7 million ...

Like other aspects of consumer data analysis, marketing is becoming more about personalization, said Brett Downes, director at Haro Helpers. “Mapping users’ journeys and personalizing their ...

As reported in the final analysis, 2 toxicity was manageable. These data support pembrolizumab plus chemotherapy as a standard-of-care first-line treatment option for metastatic squamous NSCLC, ...

This two-part article discusses the various legal and evidentiary requirements for antedating and removing prior art that ...

Researchers developed and validated blood and urine metabolite scores that objectively measure ultra-processed food (UPF) ...

05, relative to the gold standard of manual adjudication. External validation was performed using a data set of hospital admissions from June 1, 2018, to May 31, 2019, from a second institution.

The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024 and reach USD 187.7 billion by 2030, growing at ...

The global Artificial Intelligence in Diagnostics Market Size is projected to be valued at USD 1.97 Billion in 2025 and reach ...

Saelig Company, Inc. announces the Pico Technology PS3415E and PS3416E USB-powered 5GSa/s PC-based oscilloscopes, which are ...

North Arrow Minerals Inc. (TSXV: NAR) ("North Arrow" or the "Company") is pleased announce the start of a three-month, ...

bNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA ...

Our pooled data analysis reiterates that there is no significant statistical evidence of greater efficiency of enoxaparin over UFH in preventing mortality, MI, or urgent revascularization. 1 Bhatt DL, ...